Megan Detmer
About Megan Detmer
Megan Detmer serves as the Area Business Director at Ardelyx, Inc., where she has worked since 2023. With a background in pharmaceutical sales and compliance, she has built strong relationships with major healthcare institutions and has a successful track record in drug launches.
Current Role at Ardelyx
Megan Detmer serves as the Area Business Director at Ardelyx, Inc. since 2023. In this role, she is responsible for overseeing business operations and strategies within the San Francisco Bay Area. Her position involves collaborating with healthcare providers to improve access to specialty medications and enhance patient care.
Previous Experience in the Pharmaceutical Industry
Megan Detmer has a diverse background in the pharmaceutical industry. She worked as a Senior Territory Business Manager for GI Immunology at Bristol Myers Squibb from 2021 to 2023. Prior to that, she served as a GI Specialty Representative at Allergan and Nestlé Health Science in 2020. Her experience includes successful drug launches and building relationships with major healthcare institutions.
Experience in Healthcare Compliance
Before her roles in the pharmaceutical sector, Megan Detmer worked as a Compliance Coordinator at Contra Costa Health Plan from 2012 to 2014. In this position, she focused on ensuring adherence to healthcare regulations and policies, contributing to the organization's operational integrity.
Educational Background
Megan Detmer studied at California State University, Chico, where she earned a Bachelor's degree in Health Services Administration from 2010 to 2014. She completed her high school education at Clayton Valley High School from 2006 to 2010.
Skills and Expertise
Megan Detmer possesses extensive experience in managing territories within academic centers and large healthcare systems. She has demonstrated success in building working relationships with major healthcare institutions, including Stanford and UCSF, to enhance specialty medication access. Her background includes HUB experience and a proven track record in the pharmaceutical industry.